187 related articles for article (PubMed ID: 22233400)
21. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
Spaccarelli N; Rook AH
Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
[TBL] [Abstract][Full Text] [Related]
22. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
[TBL] [Abstract][Full Text] [Related]
23. (2S)-2′-methoxykurarinone from Sophora flavescens suppresses cutaneous T cell-attracting chemokine/CCL27 expression induced by interleukin-ß/tumor necrosis factor-α via heme oxygenase-1 in human keratinocytes.
Jeong SI; Lee YE; Jang SI
J Med Food; 2010 Oct; 13(5):1116-24. PubMed ID: 20883179
[TBL] [Abstract][Full Text] [Related]
24. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
Walker CJ; Espinosa ML; Mehta-Shah N; Pro B; Guitart J; Kuzel T
J Drugs Dermatol; 2021 Mar; 20(3):349-350. PubMed ID: 33683074
[TBL] [Abstract][Full Text] [Related]
25. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
[TBL] [Abstract][Full Text] [Related]
26. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
27. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.
Rupoli S; Goteri G; Pulini S; Filosa A; Tassetti A; Offidani M; Filosa G; Mozzicafreddo G; Giacchetti A; Brandozzi G; Cataldi I; Barulli S; Ranaldi R; Scortechini AR; Capretti R; Fabris G; Leoni P;
Eur J Haematol; 2005 Aug; 75(2):136-45. PubMed ID: 16000130
[TBL] [Abstract][Full Text] [Related]
28. Phototherapy of Mycosis Fungoides.
Hodak E; Pavlovsky L
Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
[TBL] [Abstract][Full Text] [Related]
29. Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
Anadolu RY; Birol A; Sanli H; Erdem C; Türsen U
Int J Dermatol; 2005 Jul; 44(7):559-65. PubMed ID: 15985024
[TBL] [Abstract][Full Text] [Related]
30. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
Coors EA; Von den Driesch P
Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
[No Abstract] [Full Text] [Related]
31. Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
Rupoli S; Goteri G; Morsia E; Torre E; Giantomassi F; Campanati A; Offidani AM; Molinelli E; Brandozzi G; Serresi S; Giacchetti A; Bugatti L; Filosa G; Mozzicafreddo G; Simonacci M; Olivieri A
Dermatol Ther; 2022 Oct; 35(10):e15737. PubMed ID: 35903895
[TBL] [Abstract][Full Text] [Related]
32. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
[TBL] [Abstract][Full Text] [Related]
33. Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic.
Grandi V; Delfino C; Pileri A; Pimpinelli N
Br J Dermatol; 2017 Aug; 177(2):406-410. PubMed ID: 28078669
[TBL] [Abstract][Full Text] [Related]
34. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma.
Chiarion-Sileni V; Bononi A; Fornasa CV; Soraru M; Alaibac M; Ferrazzi E; Redelotti R; Peserico A; Monfardini S; Salvagno L
Cancer; 2002 Aug; 95(3):569-75. PubMed ID: 12209749
[TBL] [Abstract][Full Text] [Related]
36. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
[TBL] [Abstract][Full Text] [Related]
37. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
38. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides.
Kato H; Saito C; Ito E; Furuhashi T; Nishida E; Ishida T; Ueda R; Inagaki H; Morita A
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):273-80. PubMed ID: 23332394
[TBL] [Abstract][Full Text] [Related]
39. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma.
Hashikawa K; Yasumoto S; Nakashima K; Arakawa F; Kiyasu J; Kimura Y; Saruta H; Nakama T; Yasuda K; Tashiro K; Kuhara S; Hashimoto T; Ohshima K
Int J Oncol; 2014 Sep; 45(3):1200-8. PubMed ID: 24970722
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
